Full-Time

Senior Technical Specialist

Instrumentation

Posted on 10/30/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Columbia, MO, USA

In Person

Category
Lab & Research (1)
Requirements
  • Ideally a College Degree or University Degree in Chemistry
  • At least 5 years of relevant experience
  • Must possess extensive hands-on experience with chromatographic equipment
  • Must have understanding of the general Standard Operating Procedures applicable to instrumentation and in depth knowledge of FDA-GLP
  • Extensive experience on calibration, maintenance and repair of laboratory equipment, and/or instrumentation troubleshooting, in the medical and/or pharmaceutical fields is mandatory
  • Attentive to details, manual dexterity, capable of handling heavy equipment, must possess strong technical problem-solving skills, ability to prioritize, good organizational and communication skills (especially written)
  • Able to function with minimal supervision
  • Fluent in English. Knowledgeable of ISO guidelines
  • GLP minded
  • Customer service oriented
  • Software: MS-Office, Analyst, Outlook
Responsibilities
  • To perform tuning of the mass spectrometric detectors
  • To perform preventative maintenance procedures of HPLC systems and mass spectrometric detectors
  • To troubleshoot and repair complex HPLC and mass spectrometric (MS) malfunctions
  • Person in charge of the inventory of consumables and parts of the chromatographic systems
  • Person responsible for scheduling chromatographic equipment maintenance, tuning, calibration, calibration and repair
  • Coaching, training, and mentorship for Instrument Service Technicians
  • To provide his technical expertise as part of the event resolution
  • To conduct all work in compliance with SOPs, GLPs, and observe all company guidelines and policies
  • Respecting Health and Safety standards in terms of personal protection, laboratory maintenance, and work procedures
  • To train laboratory employees on HPLC and MS equipment
  • To participate in the evaluation and implementation of new technologies
  • To participate and perform duties such as writing SOR and reviewing IQ/OQ protocols
  • To review and approve paperwork if needed
Desired Qualifications
  • None

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech sponsors need fewer vendors for early development, shortening timelines and reducing handoffs.
  • Certara integration strengthens proof-of-mechanism decisions and improves go-no-go confidence.
  • Novo Holdings backing supports expansion into international markets and deeper platform investment.

What critics are saying

  • ICON, Labcorp, and Parexel can bundle similar speed claims with larger global reach.
  • Low biotech funding pressures utilization, and idle clinics quickly crush CRO/CDMO margins.
  • Any manufacturing or data-integrity failure can halt multiple sponsor programs and trigger client exits.

What makes Altasciences unique

  • Founded in 1992, Altasciences evolved from Algorithme Pharma into an integrated CRO/CDMO.
  • Nine North American facilities support preclinical, clinical, bioanalytical, and manufacturing services.
  • The May 2026 Certara partnership adds model-informed drug development directly into execution.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Altasciences who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

4%
GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE